Clinical Trials Directory

Trials / Completed

CompletedNCT01152229

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine

Status
Completed
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Medstar Health Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2011-06-01
Completion
2011-07-01
First posted
2010-06-29
Last updated
2011-08-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01152229. Inclusion in this directory is not an endorsement.

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine (NCT01152229) · Clinical Trials Directory